Chronic Cutaneous Lupus Erythematosus: Depression Burden and Associated Factors.


Journal

American journal of clinical dermatology
ISSN: 1179-1888
Titre abrégé: Am J Clin Dermatol
Pays: New Zealand
ID NLM: 100895290

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 17 3 2019
medline: 26 11 2019
entrez: 17 3 2019
Statut: ppublish

Résumé

Depression may occur in up to 30% of individuals with cutaneous lupus erythematosus (CLE), many of whom may also have systemic manifestations. Chronic cutaneous lupus erythematosus (CCLE) conditions are less likely to present systemic involvement than acute and subacute conditions but more often cause permanent scarring and dyspigmentation. However, little is known about depression in those who have CCLE confined to the skin (primary CCLE). As African Americans are at high risk for primary CCLE and depression, we aimed to investigate the prevalence of and explore the risk factors for depression in a population-based cohort of predominantly Black patients with primary CCLE. This was a cross-sectional analysis of a cohort of individuals with a documented diagnosis of primary CCLE, established in metropolitan Atlanta, GA, USA. Participants were recruited from the Centers for Disease Control and Prevention (CDC) population-based Georgia Lupus Registry, multicenter dermatology clinics, community practices, and self-referrals. The Patient-Reported Outcomes Measurement Information System (PROMIS) was used to measure the primary outcome: depressive symptoms. Stand-alone questions were used to assess sociodemographics and healthcare utilization. Emotional, informational, and instrumental support were measured with PROMIS short forms, interpersonal processes of care with the IPC-29 survey, and skin-related quality of life with the Skindex-29+ tool. Of 106 patients, 92 (86.8%) were female, 91 (85.8%) were Black, 45 (42.9%) were unemployed or disabled, and 28 (26.4%) reported moderate to severe depressive symptoms. Depression severity was lower in patients who were aged ≥ 60 years, were married, or had graduated from college. Univariate analysis showed that being employed (odds ratio [OR] 0.24; 95% confidence interval [CI] 0.10-0.61), insured (OR 0.23; 95% CI 0.09-0.60), reporting higher instrumental, informational, and emotional support (OR 0.75; 95% CI 0.60-0.94; OR 0.62; 95% CI 0.49-0.78; and OR 0.48; 95% CI 0.35-0.65, respectively), visiting a primary care physician in the last year (OR 0.16; 95% CI 0.04-0.61) and reporting better physician-patient interactions (OR 0.56; 95% CI 0.37-0.87) were negatively associated with depression. Patient's perception of staff disrespect (OR 2.30; 95% CI 1.19-4.47) and worse skin-related quality of life (OR 1.04; 95% CI 1.02-1.06) rendered higher risk. In multivariate analysis, only perception of staff disrespect (OR 2.35; 95% CI 1.06-5.17) and lower emotional support (OR 0.48; 95% CI 0.35-0.66) remained associated with depression. Over one-quarter of a predominantly Black population-based cohort of individuals with primary CCLE reported moderate to severe depression, a rate three to five times higher than described previously in the general population from the same metropolitan Atlanta area. Our findings suggest that, while patient's perception of discrimination in the healthcare setting may play a role as a determinant of depression, social support may be protective. In addition to routine mental health screening and depression treatment, interventions directed at providing emotional support and improving office staff interpersonal interactions may contribute to reduce the risk of depression in patients with CCLE.

Identifiants

pubmed: 30877492
doi: 10.1007/s40257-019-00429-7
pii: 10.1007/s40257-019-00429-7
pmc: PMC6534449
mid: NIHMS1524166
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

465-475

Subventions

Organisme : NCCDPHP CDC HHS
ID : U01 DP005119
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP006488
Pays : United States
Organisme : ACL HHS
ID : U01DP005119
Pays : United States
Organisme : CDC HHS
ID : 1U01DP005119
Pays : United States

Références

Milbank Q. 1999;77(3):305-39, 274
pubmed: 10526547
Arch Gen Psychiatry. 2000 Jun;57(6):601-7
pubmed: 10839339
Br J Dermatol. 2000 Nov;143(5):983-91
pubmed: 11069507
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
J Qual Clin Pract. 2001 Dec;21(4):144-8
pubmed: 11856412
Biol Psychiatry. 2003 Aug 1;54(3):216-26
pubmed: 12893098
Can J Psychiatry. 2004 Feb;49(2):124-38
pubmed: 15065747
Acta Derm Venereol. 2004;84(3):213-7
pubmed: 15202838
Am J Orthopsychiatry. 2005 Jan;75(1):3-18
pubmed: 15709846
Health Econ. 2005 Dec;14(12):1197-215
pubmed: 15945040
Autoimmun Rev. 2005 Jun;4(5):296-302
pubmed: 15990077
Br J Dermatol. 2006 Feb;154(2):294-8
pubmed: 16433799
J Am Acad Dermatol. 2006 Mar;54(3):420-6
pubmed: 16488292
Health Serv Res. 2007 Jun;42(3 Pt 1):1235-56
pubmed: 17489912
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
Arch Dermatol. 2009 Mar;145(3):249-53
pubmed: 19289752
Arch Dermatol. 2009 Mar;145(3):255-60
pubmed: 19289753
Annu Rev Clin Psychol. 2009;5:363-89
pubmed: 19327033
Psychol Sci. 2009 Oct;20(10):1282-9
pubmed: 19765237
Arthritis Rheum. 2009 Oct 15;61(10):1462-6
pubmed: 19790117
Qual Life Res. 2010 Sep;19(7):1035-44
pubmed: 20419503
J Rheumatol. 2010 Oct;37(10):2032-8
pubmed: 20634244
Arch Dermatol. 2011 Feb;147(2):203-8
pubmed: 21339447
J Am Acad Dermatol. 2011 May;64(5):849-58
pubmed: 21397983
Lupus. 2011 Oct;20(12):1285-92
pubmed: 21813589
J Clin Nurs. 2012 Jan;21(1-2):111-20
pubmed: 22017561
Dermatol Clin. 2012 Apr;30(2):231-6, xiii
pubmed: 22284137
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S486-90
pubmed: 22588770
Virtual Mentor. 2011 Dec 01;13(12):873-9
pubmed: 23137425
Lupus. 2013 Apr;22(5):409-16
pubmed: 23427220
BMC Public Health. 2013 Apr 30;13:414
pubmed: 23631737
Semin Arthritis Rheum. 2013 Oct;43(2):209-16
pubmed: 23731530
Br J Dermatol. 2014 Feb;170(2):315-21
pubmed: 24111880
JAMA Dermatol. 2014 Mar;150(3):296
pubmed: 24477964
Arthritis Rheumatol. 2014 Feb;66(2):357-68
pubmed: 24504808
Psychol Assess. 2014 Jun;26(2):513-27
pubmed: 24548149
BMJ Qual Saf. 2014 Aug;23(8):659-66
pubmed: 24614054
J Rheumatol. 2014 Sep;41(9):1823-33
pubmed: 25128512
Arthritis Care Res (Hoboken). 2015 Mar;67(3):417-24
pubmed: 25132660
Arthritis Care Res (Hoboken). 2015 May;67(6):817-28
pubmed: 25369985
J Invest Dermatol. 2015 Apr;135(4):984-991
pubmed: 25521458
J Invest Dermatol. 2015 Dec;135(12):3183-3186
pubmed: 26316069
Br J Dermatol. 2016 May;174(5):1051-60
pubmed: 26748551
J Am Acad Dermatol. 2016 Feb;74(2):377-9
pubmed: 26775780
JAMA. 2016 Jan 26;315(4):380-7
pubmed: 26813211
Ann Intern Med. 2016 Mar 1;164(5):350-9
pubmed: 26857948
Rheum Dis Clin North Am. 2016 May;42(2):253-263
pubmed: 27133488
Postepy Dermatol Alergol. 2017 Feb;34(1):36-41
pubmed: 28261029
Qual Health Res. 2018 Jan;28(1):73-86
pubmed: 29192872
Prev Med. 2018 May;110:9-15
pubmed: 29421445
J Dermatol. 2018 Apr;45(4):436-443
pubmed: 29423919
Lupus. 2018 Jun;27(7):1107-1115
pubmed: 29514557
Arthritis Care Res (Hoboken). 2019 Jan;71(1):95-103
pubmed: 29669194
Br J Dermatol. 2018 Nov;179(5):1095-1101
pubmed: 29885269
J Clin Rheumatol. 2018 Oct;24(7):368-374
pubmed: 29912774
Semin Arthritis Rheum. 2019 Feb;48(4):669-677
pubmed: 30075991
Int J Womens Dermatol. 2018 Apr 13;4(3):152-158
pubmed: 30175217
Arthritis Care Res (Hoboken). 2018 Oct 24;:
pubmed: 30354017
Lupus. 2019 Feb;28(2):253-260
pubmed: 30482093
J Invest Dermatol. 1996 Nov;107(5):707-13
pubmed: 8875954
Lupus. 1997;6(2):96-104
pubmed: 9061657
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Arch Dermatol. 1997 Nov;133(11):1433-40
pubmed: 9371029

Auteurs

Jennifer Hong (J)

Department of Medicine and Department of Epidemiology, Emory University, Atlanta, GA, USA.

Laura Aspey (L)

Department of Medicine and Department of Dermatology, Emory University, Atlanta, GA, USA.

Gaobin Bao (G)

Department of Medicine, Division of Rheumatology, Emory University, Atlanta, GA, USA.

Tamara Haynes (T)

Department Medicine and Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.

S Sam Lim (SS)

Department of Medicine, Division of Rheumatology, Emory University, Atlanta, GA, USA.

Cristina Drenkard (C)

Department of Medicine, Division of Rheumatology, Emory University, Atlanta, GA, USA. cdrenka@emory.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH